Angiotensin II Receptor Type 1 Expression in Erythroid Progenitors: Implications for the Pathogenesis of Postrenal Transplant Erythrocytosis

Seminars in Nephrology

Volumn 24, Issue 2, 2004, Pages 120-130

  Mrug, Michal ^b   Julian, Bruce A ^b   Prchal, Josef T ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; ANDROGEN; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BASIC FIBROBLAST GROWTH FACTOR; CALCIUM ION; CD34 ANTIGEN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1; INTERLEUKIN 3; INTERLEUKIN 6; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR A; SOMATOMEDIN C; STEM CELL FACTOR; THROMBOPOIETIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANEMIA; BURST FORMING UNIT E; CALCIUM MOBILIZATION; COLONY FORMING UNIT E; DRUG EFFICACY; ENZYME ACTIVATION; ERYTHROCYTE; ERYTHROCYTOSIS; HEMATOPOIETIC STEM CELL; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; MODEL; NONHUMAN; ORGAN TRANSPLANTATION; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION;

EID: 1642321849     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2003.11.006     Document Type: Article

References (96)

1. Gregory CJ, Eaves AC: Three stages of erythropoietic progenitor cell differentiation distinguished by a number of physical and biologic properties. Blood 51:527-537, 1978
2. Wickrema A, Krantz SB, Winkelmann JC, et al: Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells. Blood 80:1940-1949, 1992
3. Sawada K, Krantz SB, Dai CH, et al: Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors. J Cell Physiol 142:219-230, 1990
4. Ang SO, Chen H, Hirota K, et al: Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 32:614-621, 2002
5. Semenza GL: HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 13:167-171, 2001
6. Epstein AC, Gleadle JM, McNeill LA, et al: C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43-54, 2001
7. Ivan M, Kondo K, Yang H, et al: HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science 292:464-468, 2001
8. Jaakkola P, Mole DR, Tian YM, et al: Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468-472, 2001
9. Cashman JD, Eaves AC, Raines EW, et al: Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-β. Blood 75:96-101, 1990
10. Shao L, Frigon NL Jr, Young AL, et al: Effect of activin A on globin gene expression in purified human erythroid progenitors. Blood 79:773-781, 1992
11. Clark SC, Kamen R: The human hematopoietic colony-stimulating factors. Science 236:1229-1237, 1987
12. Bernstein A, Forrester L, Reith AD, et al: The murine W/c-kit and Steel loci and the control of hematopoiesis. Semin Hematol 28:138-142, 1991
13. Mrug M, Stopka T, Julian BA, et al: Angiotensin 11 stimulates proliferation of normal early erythroid progenitors. J Clin Invest 100:2310-2314, 1997
14. Malgor LA, Valsecia M, Verges E, et al: Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide. Acta Physiol Pharmacol Ther Latinoam 48:99-105, 1998
15. Kaushansky K, Broudy VC, Grossmann A, et al: Thrombopoietin expands erythroid progenitors, increases red cell production and enhances erythroid recovery after myelosuppressive therapy. J Clin Invest 96:1683-1687, 1995
16. Le Meur Y, Lorgeot V, Comte L, et al: Plasma levels and metabolism of AcSDKP in patients with chronic renal failure: Relationship with erythropoietin requirements. Am J Kidney Dis 38:510-517, 2001
17. Kanasaki K, Koya D, Sugimoto T, et al: N-acetyl-seryl-aspartyl-lysyl-proline inhibits TGF-β-mediated plasminogen activator inhibitor-1 expression via inhibition of Smad pathway in human mesangial cells. J Am Soc Nephrol 14:863-872, 2003
18. Onoyama K, Sanai T, Motomura K, et al: Worsening of anemia by angiotensin converting enzyme inhibitors and its prevention by antiestrogenic steroid in chronic hemodialysis patients. J Cardiovasc Pharmacol 13:S27-S30, 1989 (suppl 3)
19. Bailey RR, Sizeland PC: ACE inhibitor anaemia. N Z Med J 102:232, 1989
20. Verhaaren HA, Vande Walle J, Devloo-Blancquaert A: Captopril in severe childhood hypertension-Reversible anaemia with high dosage. Eur J Pediatr 144:554-556, 1986
21. Sizeland PC, Bailey RR, Lynn KL, et al: Anemia and angiotensin-converting enzyme inhibition in renal transplant recipients. J Cardiovasc Pharmacol 16:S117-S119, 1990 (Suppl 7)
22. Gossmann J, Kachel HG, Schoeppe W, et al: Anemia in renal transplant recipients caused by concomitant therapy with azathioprine and angiotensin-converting enzyme inhibitors. Transplantation 56:585-589, 1993
23. Vlahakos DV, Canzanello VJ, Madaio MP, et al: Enalapril-associated anemia in renal transplant recipients treated for hypertension. Am J Kidney Dis 17:199-205, 1991
24. Hu RH, Lee PH, Lee CJ: Erythropoietin, interleukin-3, interleukin-11, and GM-CSF in posttransplant erythrocytosis treated with enalapril. Transplant Proc 28:1545-1547, 1996
25. Montanaro D, Gropuzzo M, Tulissi P, et al: Angiotensin-converting enzyme inhibitors reduce hemoglobin concentrations, hematocrit, and serum erythropoietin levels in renal transplant recipients without posttransplant erythrocytosis. Transplant Proc 33:2038-2040, 2001
26. Glicklich D, Burris L, Urban A, et al: Angiotensin-converting enzyme inhibition induces apoptosis in erythroid precursors and affects insulin-like growth factor-1 in posttransplantation erythrocytosis. J Am Soc Nephrol 12:1958-1964, 2001
27. Morrone LF, Di Paolo S, Logoluso F, et al: Interference of angiotensin-converting enzyme inhibitors on erythropoiesis in kidney transplant recipients: Role of growth factors and cytokines. Transplantation 64:913-918, 1997
28. Conlon PJ, Farrell J, Donohoe J, et al: The beneficial effect of enalapril on erythrocytosis after renal transplantation. Transplantation 56:217-219, 1993
29. Gossmann J, Thurmann P, Bachmann T, et al: Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipients. Kidney Int 50:973-978, 1996
30. Kessler M, Hestin D, Mayeux D, et al: Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study. Clin Nephrol 45:83-89, 1996
31. Danovitch GM, Jamgotchian NJ, Eggena PH, et al: Angiotensin-converting enzyme inhibition in the treatment of renal transplant erythrocytosis. Clinical experience and observation of mechanism. Transplantation 60:132-137, 1995
32. Perazella M, McPhedran P, Kliger A, et al: Enalapril treatment of posttransplant erythrocytosis: Efficacy independent of circulating erythropoietin levels. Am J Kidney Dis 26:495-500, 1995
33. Rodgers KE, Xiong S, Steer R, et al: Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells 18:287-294, 2000
34. Glezerman I, Patel H, Glicklich D, et al: Angiotensin-converting enzyme inhibition induces death receptor apoptotic pathways in erythroid precursors following renal transplantation. Am J Nephrol 23:195-201, 2003
35. Cole J, Ertoy D, Lin H, et al: Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice. J Clin Invest 106:1391-1398, 2000
36. Anagnostou A, Baranowski R, Pillay VK, et al: Effect of renin on extrarenal erythropoietin production. J Lab Clin Med 88:707-715, 1976
37. Nakao K, Shirakura T, Azuma M, et al: Studies on erythropoietic action of angiotensin II. Blood 29:754-760, 1967
38. Fisher JW, Samuels AI, Langston JW: Effects of angiotensin and renal artery constriction on erythropoietin production. J Pharmacol Exp Ther 157:618-625, 1967
39. Fried W, Barone-Varelas J, Barone T, et al: Extraction of erythropoietin from kidneys. Exp Hematol 8:41-51, 1980 (suppl 8)
40. Gould AB, Goodman S, DeWolf R, et al: Interrelation of the renin system and erythropoietin in rats. J Lab Clin Med 96:523-534, 1980
41. Gossmann J, Burkhardt R, Harder S, et al: Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway. Kidney Int 60:83-86, 2001
42. Freudenthaler SM, Schreeb K, Korner T, et al: Angiotensin II increases erythropoietin production in healthy human volunteers. Eur J Clin Invest 29:816-823, 1999
43. Donnelly S: Why is erythropoietin made in the kidney? The kidney functions as a critmeter. Am J Kidney Dis 38:415-425, 2001
44. Wang GL, Semenza GL: General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 90:4304-4308, 1993
45. Jackson TR, Blair LA, Marshall J, et al: The mas oncogene encodes an angiotensin receptor. Nature 335:437-440, 1988
46. Weber H, Taylor DS, Molloy CJ: Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin. J Clin Invest 93:788-798, 1994
47. Rodgers K, Xiong S, Felix J, et al: Development of angiotensin (1-7) as an agent to accelerate dermal repair. Wound Repair Regen 9:238-247, 2001
48. Stouffer GA, Owens GK: Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-β. Circ Res 70:820-828, 1992
49. Nakahara K, Nishimura H, Kuro-O M, et al: Identification of three types of PDGF-A chain gene transcripts in rabbit vascular smooth muscle and their regulated expression during development and by angiotensin II. Biochem Biophys Res Commun 184:811-818, 1992
50. Gupta M, Miller BA, Ahsan N, et al: Expression of angiotensin II type I receptor on erythroid progenitors of patients with post transplant erythrocytosis. Transplantation 70:1188-1194, 2000
51. Rodgers K, Xiong S, DiZerega GS: Effect of angiotensin II and angiotensin (1-7) on hematopoietic recovery after intravenous chemotherapy. Cancer Chemother Pharmacol 51:97-106, 2003
52. Azizi M, Rousseau A, Ezan E, et al: Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest 97:839-844, 1996
53. De Paolis P, Porcellini A, Savoia C, et al: Functional cross-talk between angiotensin II and epidermal growth factor receptors in NIH3T3 fibroblasts. J Hypertens 20:693-699, 2002
54. Carroll MP, Spivak JL, McMahon M, et al: Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation. J Biol Chem 266:14964-14969, 1991
55. Okuda M, Kawahara Y, Yokoyama M: Angiotensin II type I receptor-mediated activation of Ras in cultured rat vascular smooth muscle cells. Am J Physiol 271:H595-H601, 1996
56. 2 receptors in regulation of MAPKs and MKP-1 by ANG II in adult cardiac myocytes. Am J Physiol 275:H906-H916, 1998
57. Gobert S, Duprez V, Lacombe C, et al: The signal transduction pathway of erythropoietin involves three forms of mitogen-activated protein (MAP) kinase in UT7 erythroleukemia cells. Eur J Biochem 234:75-83, 1995
58. Marrero MB, Schieffer B, Paxton WG, et al: Direct stimulation of Jak/ STAT pathway by the angiotensin II AT1 receptor. Nature 375:247-250, 1995
59. Wang Y, Morella KK, Ripperger J, et al: Receptors for interleukin-3 (IL-3) and growth hormone mediate an IL-6-type transcriptional induction in the presence of JAK2 or STAT3. Blood 86:1671-1679, 1995
60. Wang Y, Fuller GM: Phosphorylation and internalization of gp130 occur after IL-6 activation of Jak2 kinase in hepatocytes. Mol Biol Cell 5:819-828, 1994
61. Quelle FW, Sato N, Witthuhn BA, et al: JAK2 associates with the β c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol 14:4335-4341, 1994
62. Linnekin D, Weiler SR, Mou S, et al: JAK2 is constitutively associated with c-Kit and is phosphorylated in response to stem cell factor. Acta Haematol 95:224-228, 1996
63. Jiang N, He TC, Miyajima A, et al: The box1 domain of the erythropoietin receptor specifies Janus kinase 2 activation and functions mitogenically within an interleukin 2 β-receptor chimera. J Biol Chem 271:16472-16476, 1996
64. Miller BA, Bell L, Hansen CA, et al: G-protein α subunit Gi(α)2 mediates erythropoietin signal transduction in human erythroid precursors. J Clin Invest 98:1728-1736, 1996
65. Loutzenhiser K, Loutzenhiser R: Angiotensin II-induced Ca(2+) influx in renal afferent and efferent arterioles: differing roles of voltage-gated and store-operated Ca(2+) entry. Circ Res 87:551-557, 2000
66. Carozzi S, Grazia Nasini M, Salit M, et al: Ca(++)-induced modulation of erythropoiesis in polycythemic transplanted patients. Transplant Proc 23:1309-1311, 1991
67. Stopka T, Zivny JH, Stopkova P, et al: Human hematopoietic progenitors express erythropoietin. Blood 91:3766-3772, 1998
68. Prchal JT: Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders. Semin Hematol 38:10-20, 2001
69. Thevenod F, Radtke HW, Grutzmacher P, et al: Deficient feedback regulation of erythropoiesis in kidney transplant patients with polycythemia. Kidney Int 24:227-232, 1983
70. Dagher FJ, Ramos E, Erslev AJ, et al: Are the native kidneys responsible for erythrocytosis in renal allorecipients? Transplantation 28:496-498, 1979
71. Gaston RS, Julian BA, Curtis JJ: Posttransplant erythrocytosis: An enigma revisited. Am J Kidney Dis 24:1-11, 1994
72. Lezaic V, Biljanovic-Paunovic L, Pavlovic-Kentera V, et al: Erythropoiesis after kidney transplantation: The role of erythropoietin, burst promoting activity and early erythroid progenitor cells. Eur J Med Res 6:27-32, 2001
73. Lezaic V, Djukanovic LJ, Pavlovic-Kentera V, et al: Factors inducing posttransplant erythrocytosis. Eur J Med Res 2:407-412, 1997
74. Qunibi WY, Barri Y, Devol E, et al: Factors predictive of post-transplant erythrocytosis. Kidney Int 40:1153-1159, 1991
75. Sumrani NB, Daskalakis P, Miles AM, et al: Erythrocytosis after renal transplantation. A prospective analysis. ASAIO J 39:51-55, 1993
76. Friman S, Nyberg G, Blohme I: Erythrocytosis after renal transplantation; treatment by removal of the native kidneys. Nephrol Dial Transplant 5:969-973, 1990
77. Aeberhard JM, Schneider PA, Vallotton MB, et al: Multiple site estimates of erythropoietin and renin in polycythemic kidney transplant patients. Transplantation 50:613-616, 1990
78. Julian BA, Gaston RS, Barker CV, et al: Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis. Kidney Int 46:1397-1403, 1994
79. Gaston RS, Julian BA, Barker CV, et al: Enalapril: Safe and effective therapy for posttransplant erythrocytosis. Transplant Proc 25:1029-1031, 1993
80. Sauron C, Berthoux P, Berthoux F, et al: New insights and treatment in posttransplant polycythemia (erythrocytosis) of renal recipients. Transplant Proc 25:1032-1033, 1993
81. Glicklich D, Kapoian T, Mian H, et al: Effects of erythropoietin, angiotensin II, and angiotensin-converting enzyme inhibitor on erythroid precursors in patients with posttransplantation erythrocytosis. Transplantation 68:62-66, 1999
82. Teruel JL, Marcen R, Navarro JF, et al: Evolution of serum erythropoietin after androgen administration to hemodialysis patients: A prospective study. Nephron 70:282-286, 1995
83. Chen YF, Naftilan AJ, Oparil S: Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension 19:456-463, 1992
84. Yanase T, Maki T, Nawata H, et al: Effect of angiotensin II on secretion of adrenal androgens. Endocrinol Jpn 31:741-747, 1984
85. Wang AY, Yu AW, Lam CW, et al: Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis. Am J Kidney Dis 39:600-608, 2002
86. Montanaro D, Groupuzzo M, Boscutti G, et al: Long-term therapy for postrenal transplant erythrocytosis with ACE inhibitors: Efficacy, safety and action mechanisms. Clin Nephrol 53:47-51, 2000
87. Calvino J, Lens XM, Romero R, et al: Long-term antiproteinuric effect of Losartan in renal transplant recipients treated for hypertension. Nephrol Dial Transplant 15:82-86, 2000
88. Shih LY, Huang JY, Lee CT: Insulin-like growth factor 1 plays a role in regulating erythropoiesis in patients with end-stage renal disease and erythrocytosis. J Am Soc Nephrol 10:315-322, 1999
89. Muller C, Reddert A, Wassmann S, et al: Insulin-like growth factor induces up-regulation of AT(1)-receptor gene expression in vascular smooth muscle cells. J Renin Angiotensin Aldosterone Syst 1:273-277, 2000
90. Lamperi S, Carozzi S: Erythroid progenitor growth in erythrocytosic transplanted patients. Artif Organs 9:200-204, 1985
91. Rostaing L, Demur C, Huyn A, et al: Erythrocytosis after renal transplant: Study of erythroid progenitors and response to enalapril. Transplant Proc 26:280-281, 1994
92. Smalcelj R, Kusec V, Thune S, et al: Circulating hematopoietic progenitors are not altered in patients with post-transplant erythrocytosis. Haematologica 83:948-949, 1998
93. Hestin D, Gregoire MJ, Mayeux D, et al: In-vitro growth patterns of bone marrow erythroid progenitors from patients with post-renal transplant erythrocytosis. Nephrol Dial Transplant 13:1776-1781, 1998
94. Ducloux D, Saint-Hillier Y, Chalopin JM: Effect of losartan on haemoglobin concentration in renal transplant recipients - a retrospective analysis. Nephrol Dial Transplant 12:2683-2686, 1997
95. Goldberg MA, Dunning SP, Bunn HF: Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science 242:1412-1415, 1988
96. Koury MJ, Bondurant MC: Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248:378-381, 1990